Form 4: Modular Medical COO Kevin Schmid Receives Stock Options

Modular Medical, Inc. Chief Operating Officer Kevin Schmid was granted 4,674 stock options as part of an equity incentive.

Summary

• Chief Operating Officer Kevin Schmid received an option grant to purchase 4,674 shares of common stock.
• The options have an exercise price of $3.46 per share.
• The grant date for these options is May 14, 2026.
• The options are set to expire on May 14, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation that carries no significant change to the company's financial outlook.

Positives

• Aligns executive compensation with long-term shareholder value through equity-based incentives.

Negatives

• The grant results in potential future dilution for existing shareholders upon exercise.

Risks

• The value of the options is dependent on the future market performance of the company's common stock.

Future Outlook

The options vest over a three-year period, with 1/3rd vesting on May 14, 2027, and the remainder vesting monthly thereafter, indicating a long-term retention incentive for the COO.

Industry Context

StockSavvy.ai notes that equity grants to C-suite executives are standard practice in the medical device sector to ensure leadership alignment with company growth milestones and shareholder interests.

Comparison to Industry Standards

• The use of time-based vesting schedules (1/3rd after one year, then monthly) is consistent with standard corporate governance practices for executive equity compensation.

Stakeholder Impact

• Minor potential dilution for shareholders upon the eventual exercise of the options.

Next Steps

• Vesting of the first tranche of options on May 14, 2027.

Key Dates

Keywords

Modular Medical, MODD, Form 4, Insider Trading, Stock Options, Executive Compensation